v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating activities      
Net income $ 4,526 $ 4,302 $ 4,989
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:      
Depreciation and amortization 405 220 240
Stock-based compensation 567 564 542
Deferred income tax expense (benefit) 17 (226) (1,221)
Contingent consideration fair value adjustments 53 65 8
Other gains (30) (50)  
Net (gains) losses within consolidated sponsored investment products (254) 149 (218)
Net (purchases) proceeds within consolidated sponsored investment products (1,746) (1,938) (570)
(Earnings) losses from equity method investees (116) (94) (122)
Distributions of earnings from equity method investees 70 30 35
Changes in operating assets and liabilities:      
Accounts receivable (433) 4 (521)
Investments, trading (21) 179 146
Other assets 141 (223) (173)
Accrued compensation and benefits 58 (230) 276
Accounts payable and accrued liabilities (111) 43 308
Other liabilities (242) 280 231
Net cash provided by/(used in) operating activities 2,884 3,075 3,950
Investing activities      
Purchases of investments (693) (327) (489)
Proceeds from sales and maturities of investments 417 449 166
Distributions of capital from equity method investees 136 24 32
Net consolidations (deconsolidations) of sponsored investment funds (110) (51) (60)
Acquisitions, net of cash acquired (1,510) (699) (102)
Purchases of property and equipment (254) (204) (155)
Net cash provided by/(used in) investing activities (2,014) (808) (608)
Financing activities      
Proceeds from long-term borrowings 992   697
Repayments of long-term borrowings (1,000)   (700)
Cash dividends paid (2,096) (1,968) (1,662)
Repurchases of common stock (1,911) (2,087) (1,421)
Net proceeds from (repayments of) borrowings by consolidated sponsored investment products 111 40  
Net (redemptions/distributions paid)/subscriptions received from noncontrolling interest holders 1,458 1,263 464
Other financing activities (137) (13) (8)
Net cash provided by/(used in) financing activities (2,583) (2,765) (2,630)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 54 (93) 192
Net increase (decrease) in cash, cash equivalents and restricted cash (1,659) (591) 904
Cash, cash equivalents and restricted cash, beginning of year 6,505 7,096 6,192
Cash, cash equivalents and restricted cash, end of year 4,846 6,505 7,096
Supplemental disclosure of cash flow information:      
Interest 193 177 205
Income taxes (net of refunds) 1,168 1,159 1,124
Supplemental schedule of noncash investing and financing transactions:      
Issuance of common stock 549 652 626
PNC preferred stock capital contribution 60 58 193
Increase (decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds $ (1,292) $ (560) $ (281)